The breadth of selling across multiple C-suite and senior officers at similar prices suggests a coordinated event (e.g., tax-related or post-vesting liquidity) rather than a negative signal. However, the absence of any open-market buying in the cluster and the concentration of sales near $199 warrants monitoring for any subsequent negative corporate disclosures or earnings pre-announcements.
Price Chart
Executive Summary
Eight Revolution Medicines insiders sold a total of $6.07M in open-market sales over a one-week window, including the COO, CFO, and General Counsel. The cluster is dominated by a single large $2.75M sale by Mark Goldsmith, with most trades concentrated on September 16 at ~$199.30. While the dollar value is modest relative to the company's market cap (approximately 0.2%), the breadth of C-suite and senior officer participation is notable and suggests coordinated portfolio rebalancing or tax planning rather than a reaction to imminent news.
Key Financial Metrics
Key Facts
- Eight insiders sold shares totaling $6.07M in open-market sales from September 15-22, 2026.
- Largest seller: Mark A. Goldsmith sold 13,800 shares for $2.75M at $199.30.
- COO Margaret Horn sold 4,900 shares for $975K; General Counsel Jeff Cislini sold 3,300 shares for $660K.
- CFO Jack Anders sold only 61 shares for $12K, a minimal position reduction.
- All sales were open-market (code S) with no 10b5-1 plan indication in the data.
- Total sales represent approximately 0.2% of RVMD's market cap (estimated ~$3B based on ~$200 share price).
Financial Impact
Insider selling of $6.07M, approximately 0.2% of market cap.
Risk Factors
- Potential negative catalyst if insiders continue selling into weakness.
- No insider buying to offset the selling signal.
- Cluster selling may weigh on near-term sentiment.
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-RVMD-1790287235608 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | Institutional Cluster | $186.99 | awaiting T+60 | — | $186.22 (−0.41%) |
Oct 21, 2026 6d ago | Press Release | $187.69 | awaiting T+60 | — | $186.22 (−0.78%) |
Oct 13, 2026 14d ago | 8-K | $193.52 | awaiting T+60 | — | $186.22 (−3.77%) |
Oct 12, 2026 15d ago | Institutional Cluster | $193.95 | awaiting T+60 | — | $186.22 (−3.99%) |
Oct 1, 2026 26d ago | Insider Cluster | $206.64 | awaiting T+60 | — | $186.22 (−9.88%) |
Sep 29, 2026 28d ago | Insider Cluster | $205.26 | awaiting T+60 | — | $186.22 (−9.28%) |
Sep 28, 2026 29d ago | Insider Cluster | $204.48 | awaiting T+60 | — | $186.22 (−8.93%) |
Sep 24, 2026 4w ago | Insider Cluster | $204.97 | awaiting T+60 | — | $186.22 (+9.15%) |
Sep 22, 2026 5w ago | Insider Cluster | $190.74 | awaiting T+60 | — | $186.22 (+2.37%) |
Sep 18, 2026 5w ago | Insider Cluster | $192.76 | awaiting T+60 | — | $186.22 (+3.39%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers